Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2026-04-24 16:30:10 ET · period of report 2026-04-22 · accession 0001193125-26-177400 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-04-24 16:30 | 2026-04-22 | KYMR | Chadwick Jeremy G | COO | M - OptEx | $39.06 | +300 | 61.5K | +0.5% | +$11.7K |
| DT | 2026-04-24 16:30 | 2026-04-22 | KYMR | Chadwick Jeremy G | COO | S - Sale+OE | $90.00 | -300 | 61.2K | -0.5% | -$27.0K |
| DMT | 2026-04-24 16:30 | 2026-04-22 | KYMR | Chadwick Jeremy G | COO | M - OptEx | $0.00 | -300 | 58.3K | -0.5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-22 | M | A | 100 | $30.17 | 61,302 | D | — | — | (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person. |
| 2 | Common | Common Stock | 2026-04-22 | M | A | 200 | $43.50 | 61,502 | D | — | — | (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person. |
| 3 | Common | Common Stock | 2026-04-22 | S | D | 300 | $90.00 | 61,202 | D | — | — | (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-04-22 | M | D | 100 | $0.00 | 45,434 | D | $30.17 · — to 2035-03-02 | 100 Common Stock | (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person. (F2) The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments following March 3, 2025, subject to the reporting person's continued employment through each vesting date. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-04-22 | M | D | 200 | $0.00 | 58,263 | D | $43.50 · — to 2034-02-28 | 200 Common Stock | (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person. (F3) The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments following March 1, 2024, subject to the reporting person's continued employment through each vesting date. |